Login
From:
www.news.sanofi.us
(Uncensored)
subscribe
Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
https://www.news.sanofi.us/2025-06-25-Riliprubart-earns-orphan-drug-designation-in-the-US-for-antibody-mediated-rejection-in-solid-organ-transplantation
links
backlinks
Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney transplant recipients
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
